Physician profile
Ava E Manning
NPI 1710048970
$2,820.37
in general payments reported to CMS, 2019-2025
33 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $163 · 2021: $352 · 2022: $685 · 2023: $373 · 2024: $353 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $670.51 | 2019-2023 | |
| Pfizer INC. | $306.21 | 2019-2022 | |
| Astellas Pharma US INC | $245.02 | 2023-2025 | Veozah |
| Abbvie INC. | $205.67 | 2019-2022 | |
| Daiichi Sankyo INC. | $178.54 | 2022-2025 | Injectafer |
| Exeltis, USA INC. | $135.72 | 2019-2025 | Slynd |
| Organon LLC | $103.20 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $97.57 | 2019-2024 | Paragard T 380a |
| Myovant Sciences INC. | $92.46 | 2021-2022 | |
| Avion Pharmaceuticals | $92.07 | 2019-2021 | |
| Allergan, INC. | $60.53 | 2019-2020 | |
| Hologic Sales and Service, LLC | $57.09 | 2022-2025 | Aptima |
| Aspira Women'S Health INC | $53.37 | 2022-2023 | Ova1 |
| Merck Sharp & Dohme LLC | $50.92 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $45.48 | 2022-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $33.40 | 2022-2024 | Truclear |
| Sage Therapeutics, LLC | $32.48 | 2024 | |
| Evofem Biosciences, INC. | $31.04 | 2022 | |
| Sumitomo Pharma America, INC. | $30.83 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $30.27 | 2019-2021 | |
| Convatec INC. | $27.85 | 2022-2024 | |
| Covidien Lp | $27.04 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $25.58 | 2023 | Vivjoa |
| Meditrina | $24.87 | 2022-2024 | |
| Pacira Pharmaceuticals Incorporated | $23.34 | 2025 | Exparel |
| Alexion Pharmaceuticals, INC. | $22.99 | 2022 | |
| Acessa Health INC. | $21.27 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.00 | 2020 | |
| Heron Therapeutics, INC. | $17.58 | 2024 | Zynrelef |
| Dexcom, INC. | $16.35 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $16.35 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $14.88 | 2019 | |
| Lupin INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ava Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.